Prevalence of potential drug–drug interactions in cancer patients treated with oral anticancer drugs-Reference-Cited by-同舟云学术

Prevalence of potential drug–drug interactions in cancer patients treated with oral anticancer drugs

Published:2013-02-14 Issue:5 Volume:108 Page:1071-1078
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

van Leeuwen R W F,Brundel D H S,Neef C,van Gelder T,Mathijssen R H J,Burger D M,Jansman F G A

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/bjc201348.pdf

Reference45 articles.

1. Drug Interaction Facts Version 4.0. (2006) Wolters Kluwer Health. Available at: http://www.factsandcomparisons.com (Last consulted on 16 January 2013)

2. Scientific Advisory Board of the Arizona Center for Education and Research on Therapeutics (CERT). QT Drug Lists Available at: http://www.arizonacert.org 2(Last consulted on 16 January 2013)

3. Aisner J (2007) Overview of the changing paradigm in cancer treatment: oral chemotherapy. Am J Health Syst Pharm 64 (suppl 5): S4–S7

4. Barrons R (2004) Evaluation of personal digital assistant software for drug interactions. Am J Health Syst Pharm 61: 380–385

5. Bourré-Tessier J, Haraoui B (2010) Methotrexate drug interactions in the treatment of rheumatoid arthritis: a systematic review. J Rheumatol 37: 1416–1421

Cited by 202 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proton pump inhibitors and cancer treatments: Emerging evidence against coadministration;Cancer Treatment Reviews;2024-09

2. Proton pump inhibitors decrease efficacy of palbociclib in patients with metastatic breast;Journal of Oncology Pharmacy Practice;2024-08-02

3. Survey of Potential Drug Interactions, Use of Non-Medical Health Products, and Immunization Status among Patients Receiving Targeted Therapies;Pharmaceuticals;2024-07-14

4. Clinical Pharmacy Initiatives Contribute to the Excellent Efficacy of the Dabrafenib/Trametinib Combination for Iodine-Refractory Thyroid Carcinoma: A Case Report;Medicina;2024-06-25

5. Drug-drug interactions between tyrosine kinase inhibitors and concomitance medications: Drug safety in cancer treatment;Tạp Chí Khoa Học Trường Đại Học Quốc Tế Hồng Bàng;2024-06-24